| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 09/21/2006 | US20060211704 2,4-Disubstituted thiazolyl derivatives |
| 09/21/2006 | US20060211689 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | US20060211029 Use of bridged nucleic acid fluorescent dyes, such as phenanthridinium dyes, cyanine dyes, or acridinium dyes each having an ammonium group and anion; bridging group can be -CH2-CONH-(CH2-CH2-O)x-(CH2)2-NHCO-CH2- ; low background fluorescence in the absence of nucleic acids; noncarcinogenic, stability |
| 09/21/2006 | CA2759162A1 Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors |
| 09/21/2006 | CA2600528A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | CA2599538A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | CA2599476A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/21/2006 | CA2599391A1 Crystalline forms of ziprasidone mesylate |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702919A1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 09/20/2006 | EP1702917A1 Amide derivative and medicine |
| 09/20/2006 | EP1701954A1 N-substituted piperidine and piperazine derivatives |
| 09/20/2006 | EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 09/20/2006 | EP1549624A4 Inhibitors of fatty acid amide hydrolase |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1343780B1 Piperazine derivatives for treatment of bacterial infections |
| 09/20/2006 | EP1244627B1 Picolinic acid derivatives and their use as fungicides |
| 09/20/2006 | EP1073648B1 12,13-modified epothilone derivatives |
| 09/20/2006 | CN1835949A Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors |
| 09/20/2006 | CN1835948A 2-acylaminothiazole derivative or its salt |
| 09/20/2006 | CN1835943A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/20/2006 | CN1835751A Therapeutic agents useful for treating pain |
| 09/20/2006 | CN1834095A Nonnucleoside antivirus inhibitor, its prepn. and use |
| 09/20/2006 | CN1275951C Novel benzothiazine derivatives, their preparation and use |
| 09/20/2006 | CN1275942C Benzyloxy substituted indole compound and its analog and their production method and application |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands |
| 09/19/2006 | US7109339 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/19/2006 | US7109338 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 09/19/2006 | US7109337 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/19/2006 | US7109336 Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same |
| 09/19/2006 | US7109335 5-[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-1,3-dihydro-indol-2-one; inhibitors of the FAK protein tyrosine kinases, antiproliferative, antitumor |
| 09/19/2006 | US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 09/19/2006 | US7109233 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 09/19/2006 | US7109227 Anticancer agents |
| 09/19/2006 | US7109226 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 09/19/2006 | US7109223 neuroprotective effect; potent selective agonists of the EP4 subtype of prostaglandin E2 receptors |
| 09/19/2006 | US7109222 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid; Hypercholesterolemia, hyperlipidemia, and diabetes |
| 09/19/2006 | US7109220 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109213 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 09/19/2006 | US7109207 Used to treat metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109197 Plant safening agents; nematocides; fungicides; bactericides; viricides |
| 09/19/2006 | US7109186 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment |
| 09/19/2006 | US7109150 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
| 09/19/2006 | US7108948 Organophotoreceptor with charge transport compositions |
| 09/19/2006 | CA2240845C New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/14/2006 | WO2006096652A2 Process for preparing macrocyclic compounds |
| 09/14/2006 | WO2006096358A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists |
| 09/14/2006 | WO2006096338A1 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |
| 09/14/2006 | WO2006094691A1 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS |
| 09/14/2006 | WO2006094682A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/14/2006 | WO2006094639A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | WO2006094396A1 Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions |
| 09/14/2006 | WO2006069186A3 Small molecule bcl-xl/bcl-2 binding inhibitors |
| 09/14/2006 | WO2006067445A3 Csf-1r kinase inhibitors |
| 09/14/2006 | WO2006034296A3 Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof |
| 09/14/2006 | WO2006019787A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/14/2006 | WO2005112923A3 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
| 09/14/2006 | US20060205953 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
| 09/14/2006 | US20060205947 Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions |
| 09/14/2006 | US20060205945 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/14/2006 | US20060205941 Antiinflammatory agents; inflammatory bowel disorders |
| 09/14/2006 | US20060205797 Compounds for the treatment of inflammatory disorders |
| 09/14/2006 | US20060205796 Method for treating pain or pruritis by administering opinoid receptor agonist comprising 2-phenylbenzothiazoling derivative |
| 09/14/2006 | US20060205785 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/14/2006 | US20060205744 Fused heterocyclic derivatives as ppar modulators |
| 09/14/2006 | US20060205740 Chemical compounds |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205732 Nonphytotoxic; 4-Bromo-3-methoxy-N-4-[4(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide; 4-[(Allyloxycarbonyl)amino]-3-methoxy-N-4-[4-(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide |
| 09/14/2006 | US20060205731 Novel aminopyridine compounds having Syk inhibitory activity |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | US20060205722 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 09/14/2006 | US20060205715 6-(8-Pentylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy)-nicotinamide; increase metabolic energy consumption, and reduction of weight; obesity, antidiabetic agent, eating disorders; antidepressant, anxiolytic agent |
| 09/14/2006 | CA2600367A1 Process for preparing macrocyclic compounds |
| 09/14/2006 | CA2600169A1 Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | CA2600039A1 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents |
| 09/14/2006 | CA2599974A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | CA2599250A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/13/2006 | EP1700857A1 Ziprasidone free from colored impurities and a process for its preparation |
| 09/13/2006 | EP1700856A1 Thiazole derivative |
| 09/13/2006 | EP1700850A1 Novel phenylalanine derivative |
| 09/13/2006 | EP1699784A1 Novel oxazolidinone derivatives |
| 09/13/2006 | EP1699780A1 Novel quinoline derivatives |
| 09/13/2006 | EP1699779A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 09/13/2006 | EP1699762A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension |
| 09/13/2006 | EP1699761A1 Cb1 modulator compounds |
| 09/13/2006 | EP1699455A1 Heterocyclic aspartyl protease inhibitors |
| 09/13/2006 | EP1699454A1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1414813B1 1,2,4-trioxolane antimalarials |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1392684B1 Thiazole compounds useful as inhibitors of protein kinases |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |